This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Galapagos has signed a deal to jettison its troubled JAK inhibitor drug Jyseleca, agreeing to sell the rights to rheumatoid arthritis and ulcerative colitis therapy to Italy’s Alfasigma SpA in a ...

Eberhard and colleagues noted that "only limited results are available from observational studies comparing the effectiveness ...

Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with ...

Technoderma Medicines has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

What to Expect From an Antibody-Drug Conjugate for HR+/HER2- Metastatic ... The Consumer’s Guide to JAK Inhibitors for Ankylosing Spondylitis JAK inhibitors are the newest, most targeted FDA ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...